Medindia
Advertisement

Combined Lumacaftor-Ivacaftor Therapy: Safe and Effective for Cystic Fibrosis Patients

by Bidita Debnath on May 18, 2015 at 3:33 PM
Font : A-A+

Combined Lumacaftor-Ivacaftor Therapy: Safe and Effective for Cystic Fibrosis Patients

Cystic fibrosis, a genetic disease that causes the body to create thick and sticky mucus, can now be controlled, thanks to a new breakthrough research.

In an international clinical trial, treatment with two medications, which targeted the most common genetic cause of cystic fibrosis, improved lung function and lowered the rate of pulmonary exacerbations.

Advertisement

The Combined Lumacaftor-Ivacaftor Therapy was shown to be safe and effective for cystic fibrosis patients.

The mucus formed due to this disease leads to chronic infections and increased loss of lung function. In the pancreas, the thick mucus keeps enzymes from reaching the gut to digest food. The median life expectancy is 37 years, and available treatments mostly focus on managing symptoms and consequences of the disease.
Advertisement

McColly, an Associate Director at the Cystic Fibrosis Center at Lurie Children's said, while significant progress has been made with supportive therapies for cystic fibrosis, developing treatments that address the underlying genetic cause still is a challenge.

The research claims that combining Ivacaftor with Lumacaftor helps patients with the most common cystic fibrosis mutation.

The study is published in the New England Journal of Medicine.

Source: ANI
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Sedentary Behavior Precipitates Night-Time Hot Flashes
Gonorrhea
World Alzheimer's Day 2021 - 'Know Dementia, Know Alzheimer's
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Genetic Testing of Diseases Cystic Fibrosis Fibroscan for Fatty Liver Cirrhosis and Fibrosis Retroperitoneal Fibrosis / Ormondīs Disease 

Recommended Reading
Chilean Teenager With Cystic Fibrosis Who Asked for Euthanasia on YouTube Passes Away
Valentina Maureira died on May 14 due to complications from the genetic disorder, which attacks the ...
Resistance to Anti-Viral Medication may be More Likely in Cystic Fibrosis Patients
A drug called ganciclovir is given to lung transplant patients to protect against a ......
Potential Drug That Could Help Treat Cystic Fibrosis Identified
Researchers have discovered an inhibitor for an enzyme called Sphingomyelin phosphodiesterase C ......
Antibacterial Resistance a Cause for Major Concern: Cystic Fibrosis Expert
From Queen's University Belfast, world leading Cystic Fibrosis experts have called for greater ......
Cystic Fibrosis
Cystic fibrosis is a genetic disease involving the mucus and sweat glands and the medical world has ...
Fibroscan for Fatty Liver Cirrhosis and Fibrosis
Recently, Fibroscan has incorporated the noninvasive Controlled Attenuation Parameter technique to e...
Genetic Testing of Diseases
Genetic testing helps to confirm a genetic condition in an individual and involves q complex laborat...
Retroperitoneal Fibrosis / Ormondīs Disease
Retroperitoneal fibrosis or Ormond's disease a rare disorder occurs when extra fibrous tissue forms ...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use